Sign in

CIK 0001868279 · Non-accelerated filer<br>Emerging growth company

ArriVent BioPharma, Inc.

Sign in to watch
Ticker
AVBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
240-780-6356
Business address
18 CAMPUS BLVD., SUITE 100, NEWTOWN SQUARE, PA, 19073-3269
  1. 8-K Event Regulation FD disclosure · Other events
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 8-K Event Shareholder vote results
  7. SCHEDULE 13G Stake Statement of Beneficial Ownership
  8. 10-Q Report Quarterly Report
  9. 8-K Event Results of operations
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. ARS Other Annual Report to Security Holders
  13. DEFA14A Proxy Proxy Materials
  14. DEF 14A Proxy Proxy Statement
  15. 8-K Event Executive or director change · Regulation FD disclosure
  16. 8-K Event Auditor change
  17. S-8 Other Securities Offered to Employees in Benefit Plans
  18. 8-K Event Results of operations
  19. 10-K Report Annual Report
  20. SCHEDULE 13G Stake Statement of Beneficial Ownership

Page 4 of 9 · 162 filings